Bionano Genomics Symposium 2023 featured ‘record numbers’ of presentations

Bionano Genomics announced the conclusion of Bionano’s 2023 Symposium, which was held January 23-26, 2023 and featured a record 31 oral presentations and 69 scientific posters from genomic scientists at leading institutions, including Brigham and Women’s Hospital, The University of Texas MD Anderson Cancer Center, Columbia University Medical Center and Genentech. Symposium, Bionano’s premier scientific event showcasing optical genome mapping, had over 3,000 registrants from 114 countries and averaged 750 attendees per day, an increase in daily attendance of over 32% compared to 2022. During this four-day online event, presenters reported on their use of OGM for applications in genetic disease, cancer and cell bioprocessing. "We were impressed by the engagement at our 2023 Symposium and are excited by the accomplishments of the genomic scientists from around the world who presented their data," commented Alka Chaubey, PhD, FACMG, chief medical officer at Bionano. "OGM’s ability to identify pathogenic variants was highlighted in several presentations and posters, including a poster from day one, covering a research study that resulted in a patient receiving targeted therapy as part of a clinical trial after OGM successfully detected a relevant fusion missed by conventional cytogenetic methods. Presenters showcased OGM’s potential to outperform legacy techniques, resolve decades-long questions in pathogenicity of genetic disease, and complement multiple sequencing-based methods."